M
Maria Dolores Sanchez-Niño
Researcher at Autonomous University of Madrid
Publications - 179
Citations - 36178
Maria Dolores Sanchez-Niño is an academic researcher from Autonomous University of Madrid. The author has contributed to research in topics: Kidney disease & Kidney. The author has an hindex of 50, co-authored 164 publications receiving 27206 citations. Previous affiliations of Maria Dolores Sanchez-Niño include Carlos III Health Institute & Hospital Universitario La Paz.
Papers
More filters
Journal ArticleDOI
Lyso-Gb3 modulates the gut microbiota and decreases butyrate production.
John-Jairo Aguilera-Correa,Patricia Madrazo-Clemente,María del Carmen Martínez-Cuesta,Carmen Peláez,Alberto Ortiz,Maria Dolores Sanchez-Niño,Jaime Esteban,Teresa Requena +7 more
TL;DR: Lyso-Gb3 modifies the biology of gut bacteria, favoring the production of biofilms and altering the composition and short-chain fatty-acid profile of the gut microbiota.
Journal ArticleDOI
Inflammatory Cytokines and Survival Factors from Serum Modulate Tweak-Induced Apoptosis in PC-3 Prostate Cancer Cells
Ana Belen Sanz,Maria Dolores Sanchez-Niño,Susana Carrasco,Félix Manzarbeitia,Olga Ruiz-Andres,Rafael Selgas,Marta Ruiz-Ortega,Carmen González-Enguita,Jesús Egido,Alberto Ortiz +9 more
TL;DR: TWEAK/Fn14 pathway activation promotes apoptosis in androgen-independent PC-3 cells under certain culture conditions, and characterization of the therapeutic target potential of TWEAK or Fn14 for human prostate cancer is warranted.
Journal ArticleDOI
Circulating CXCL16 in Diabetic Kidney Disease.
Usama Elewa,Maria Dolores Sanchez-Niño,Ignacio Mahillo-Fernández,Catalina Martin-Cleary,Ana Belen Sanz,Maria Vanessa Perez-Gomez,Beatriz Fernandez-Fernandez,Alberto Ortiz +7 more
TL;DR: In diabetic kidney disease patients, GFR and serum albumin independently predicted plasma CXCL16 levels, which increased with increasing eGFR category from G1 to G4 and with increasing albuminuria category.
Journal ArticleDOI
Low dose aspirin increases 15-epi-lipoxin A4 levels in diabetic chronic kidney disease patients
Marian Goicoechea,Maria Dolores Sanchez-Niño,Alberto Ortiz,Soledad García de Vinuesa,Borja Quiroga,Carmen Bernis,Enrique Morales,Gema Fernández-Juárez,Patricia de Sequera,Ursula Verdalles,Eduardo Verde,José Luño +11 more
TL;DR: Diabetic patients with CKD have lower circulating 15-epi-LXA4 levels than non-diabetic CKD patients and low dose aspirin for 12 months increased 15-EPi- LXA 4 levels in diabetic patients, which may contribute to the beneficial effects of low doses of aspirin.
Journal ArticleDOI
Chronodisruption: A Poorly Recognized Feature of CKD.
Sol Carriazo,Adrian M. Ramos,Ana Belen Sanz,Maria Dolores Sanchez-Niño,Mehmet Kanbay,Alberto Ortiz +5 more
TL;DR: Evidence for chronod isruption in CKD and the impact of chronodisruption on CKD manifestations is discussed, potential chrondisruptors are identified, some of them uremic toxins, and their therapeutic implications are discussed, and current unanswered questions on this topic are discussed.